Skip to main content

Table 2 Death and new ischemic stroke in the four ASM groups

From: Effects of long-term anti-seizure medication monotherapy on all-cause death in patients with post-stroke epilepsy: a nationwide population-based study in Taiwan

 

Phenytoin

(n = 3917)

Valproic acid

(n = 1623)

Carbamazepine

(n = 457)

New ASM

(n = 965)

P value

Mortality in the follow-up period, n (%)

237(6.1 %)

56(3.5 %)

4(0.9 %)

23(2.4 %)

< 0.0001

Interval from index date of ASM use to death, years, mean (SD)

0.9(1.1)

0.8(0.8)

1.3(1.7)

0.8(1.0)

0.5362

New ischemic stroke in the follow-up period, n (%)

83(2.1 %)

25(1.5 %)

4(0.9 %)

20(2.1 %)

< 0.0001

Interval from index date of ASM use to new ischemic stroke, years, mean (SD)

1.6(1.6)

1.4(1.2)

0.9(0.6)

1.4(1.4)

0.7513

  1. Abbreviations: ASM anti-seizure medication; SD standard deviation